Drug Shortage Report for CEFTRIAXONE SODIUM FOR INJECTION
Report ID | 131093 |
Drug Identification Number | 02287633 |
Brand name | CEFTRIAXONE SODIUM FOR INJECTION |
Common or Proper name | CEFTRIAXONE SODIUM INJ 1GM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | CEFTRIAXONE |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10pk |
ATC code | J01DD |
ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-01-06 |
Estimated end date | |
Actual end date | 2021-02-05 |
Shortage status | Resolved |
Updated date | 2021-02-12 |
Company comments | This item is discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-02-12 | French | Compare |
v3 | 2021-02-12 | English | Compare |
v2 | 2021-01-07 | French | Compare |
v1 | 2021-01-07 | English | Compare |
Showing 1 to 4 of 4